Petrus J. Bekker

2013

In 2013, Petrus J. Bekker earned a total compensation of $1.2M as Chief Medical Officer at ChemoCentryx, a 27% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$106,659
Option Awards$676,592
Salary$369,382
Other$690
Total$1,153,323

Bekker received $676.6K in option awards, accounting for 59% of the total pay in 2013.

Bekker also received $106.7K in non-equity incentive plan, $369.4K in salary and $690 in other compensation.

Rankings

In 2013, Petrus J. Bekker's compensation ranked 5,999th out of 12,286 executives tracked by ExecPay. In other words, Bekker earned more than 51.2% of executives.

ClassificationRankingPercentile
All
5,999
out of 12,286
51st
Division
Manufacturing
2,084
out of 4,612
55th
Major group
Chemicals And Allied Products
610
out of 1,462
58th
Industry group
Drugs
439
out of 1,156
62nd
Industry
Pharmaceutical Preparations
353
out of 890
60th
Source: SEC filing on April 9, 2015.

Bekker's colleagues

We found two more compensation records of executives who worked with Petrus J. Bekker at ChemoCentryx in 2013.

2013

Thomas Schall

ChemoCentryx

Chief Executive Officer

2013

Susan Kanaya

ChemoCentryx

Chief Financial Officer

In-depth

You may also like